scholarly journals Risk factors for postoperative pelvic floor dysfunction in patients with cervical cancer: evidences for management strategies

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Meng Li ◽  
Qing Tian
GYNECOLOGY ◽  
2021 ◽  
Vol 23 (2) ◽  
pp. 131-136
Author(s):  
Mekan R. Orazov ◽  
Liliia R. Toktar ◽  
Gulirano A. Karimova ◽  
Veronica Pak ◽  
Ksenia Li

The literature review presents domestic and foreign data on the relationship between pelvic floor dysfunction (PFD) and cervical diseases found in PubMed, Scopus, Embase and eLibrary systems over the past 10 years. This relationship is mainly realized due to alterations in vaginal biocenosis as the earliest clinical manifestation of PFD. The article describes PFD prevalence, classification, and risk factors for PFD. It also describes main methods of treatment and their side effects. The article provides data on changes in the vaginal biocenosis in PFD. Attention is paid to the risk for cervical intraepithelial neoplasia and cervical cancer in PFD.


Author(s):  
Sha Wang ◽  
Hongwu Wen ◽  
Yunong Gao ◽  
Qiubo Lv ◽  
Tingting Cao ◽  
...  

<b><i>Objectives:</i></b> Our study aimed to evaluate the quality of life (QoL) and pelvic floor function of cervical cancer (CC) patients after treatment. <b><i>Design:</i></b> This was a cross-sectional observational cohort study. <b><i>Participants:</i></b> The participants included in this study were CC patients who underwent radical hysterectomy (RH) from 2012 to 2018 at 18 medical centers across China. <b><i>Methods:</i></b> The validated versions of the Pelvic floor Distress Inventory-Short Form 20, Overactive Bladder Symptom Score, and Euro Qol Five-Dimension questionnaires were used to evaluate postoperative pelvic floor dysfunction (PFD) and QoL. <b><i>Results:</i></b> A total of 689 CC patients were enrolled. The incidence of stress urinary incontinence (SUI), incomplete urinary emptying, and constipation were 32.7, 27.7, and 28.6%, respectively. Multivariate analysis confirmed that laparoscopic RH (LRH) and vaginal wall resection greater than 3 cm were risk factors for lower urinary tract symptoms (LUTS). LRH and chemotherapy were risk factors for SUI. Chemoradiotherapy and LRH were risk factors for overactive bladder (OAB). A high body mass index and LRH were risk factors for more severe defecation symptoms. ARH and large amount of operative blood loss were risk factors for poor QoL. <b><i>Conclusion:</i></b> PFD is common in CC patients after treatment. LRH seems to increase the postoperative distress, including LUTS and defecation symptoms. Postoperative urinary incontinence and OAB are more bothersome for patients undergoing chemotherapy and radiotherapy. We recommend evaluating pelvic floor function as a standard assessment during follow-up.


2009 ◽  
Vol 29 (1) ◽  
pp. 34-35
Author(s):  
M. Serati ◽  
S. Salvatore ◽  
V. Khullar ◽  
S. Uccella ◽  
E. Bertelli ◽  
...  

2022 ◽  
Author(s):  
Silvia Giagio ◽  
Andrea Turolla ◽  
Tiziano Innocenti ◽  
Stefano Salvioli ◽  
Giulia Gava ◽  
...  

Background/aim: Several epidemiological studies have found a high prevalence of Pelvic Floor Dysfunction (PFD) among female athletes. However, according to several authors, these data could even be underestimated, both in research and clinical practice. Screening for potential PFD is often delayed and risk factors are not often evaluated. As a consequence, withdrawal from sport, negative influence on performance, worsening symptoms and unrecognized diagnosis may occur. The aim of our research is to develop a screening tool for pelvic floor dysfunction in female athletes useful for clinicians (musculoskeletal/sport physiotherapists, sports medicine physicians, team physicians) to guide referral to a PFD expert (e.g. pelvic floor/women's health physiotherapist, gynecologist, uro-gynecologist, urologist). Methods: A 2-round modified Delphi study will be conducted to ascertain expert opinion on which combination of variables and risk factors should be included in the screening tool. Conclusion: The implementation of the present screening tool into clinical practice may facilitate the referral to a PFD expert for further assessment of the pelvic floor and therefore, to identify potential dysfunction and, eventually, the related treatment pathway.


2008 ◽  
Vol 87 (3) ◽  
pp. 313-318 ◽  
Author(s):  
Maurizio Serati ◽  
Stefano Salvatore ◽  
Vik Khullar ◽  
Stefano Uccella ◽  
Evelina Bertelli ◽  
...  

PLoS ONE ◽  
2020 ◽  
Vol 15 (6) ◽  
pp. e0234389
Author(s):  
Taís Pereira Miguel ◽  
Carla Elaine Laurienzo ◽  
Eliney Ferreira Faria ◽  
Almir José Sarri ◽  
Isabela Queiroz Castro ◽  
...  

Author(s):  
Tapaswini Hota ◽  
Sujata Misra

Background: It is a study to determine whether or not, the widening of GH and PB with valsalva is evidence of pelvic floor dysfunction, and by the logic should the values in POPQ staging, be taken at valsalva or at rest.Methods: Prospective 2 arm cohort study. However, the analysis of various risk factors for prolapse was done in a case control study manner.Results: As compared to women without prolapse, in patients with POP, the dimensions of GH and PB are higher. Also, the increase in their dimensions with valsalva is more in prolapse cases. So valsalving while measurement of GH and PB would give a better idea of pelvic floor dysfunction.Conclusions: The study shows association between the severity of urinary problems and degree of prolapse. Measurements of POPQ when taken during valsalva, tend to give a better picture of levator dysfunction in prolapse patients.


Sign in / Sign up

Export Citation Format

Share Document